Tizanidine
- Product NDC
- 71610-345
- 11-digit product format
- 716100345
- Labeler code
- 71610
- Product ID
- 71610-345_3bf538d4-6ba2-4d28-a7a7-02dc45819d30
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA076416
- Marketing category
- ANDA
- Marketing start
- 2015-07-28
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71610-345-09 | Tizanidine | 9000 in 1 BOTTLE | TABLET | 9000 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-345 | TIZANIDINE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC, 1 package rows | 20191017_df8afbf5-c83a-4149-a63c-5e8245055204.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-345-09 | 71610034509 | 9000 TABLET in 1 BOTTLE (71610-345-09) | 9000 tablet | 2019-09-23 | 0000-00-00 | No | No | Current |